Stella Charalampopoulou

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemia.

Increased LEF1 protein levels and isoform switching drive cell proliferation in chronic lymphocytic leukemia.

Journal: Blood
Published: May 28, 2025

The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma.

The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma.

Journal: Blood cancer journal
Published: April 09, 2025

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

Journal: Blood
Published: April 01, 2025

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Journal: Blood
Published: April 01, 2025

Identification of two epitypes of IGHV unmutated chronic lymphocytic leukemia with distinct B-cell-related epigenetic imprinting and genetic alterations.

Identification of two epitypes of IGHV unmutated chronic lymphocytic leukemia with distinct B-cell-related epigenetic imprinting and genetic alterations.

Journal: HemaSphere
Published: February 24, 2025

Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia.

Dual biological role and clinical impact of de novo chromatin activation in chronic lymphocytic leukemia.

Journal: Blood
Published: May 21, 2024

Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.

Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.

Journal: Blood advances
Published: April 03, 2024

FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.

FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.

Journal: The Journal of clinical investigation
Published: July 11, 2023

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Journal: Nature communications
Published: February 02, 2023

Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.

Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.

Journal: Nature communications
Published: January 17, 2022

Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma.

Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma.

Journal: Leukemia
Published: November 05, 2020

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma.

Journal: Genome research
Published: May 08, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026